Marketing-authorisation holder · United States
Amneal Pharms Ny
2 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
United States2
Ireland1
Spain1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| KITPROZY120mg/2ml (60mg/ml), 2ml | 60mg/ml, 2/ml · Vial | Carfilzomib | United States | Marketed | 2026 |
| REPREXAIN10mg; 200mg | 2.5mg; 200mg · Tablet | Hydrocodone, Ibuprofen | United States | Not marketed | 2004 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
U.S. Food and Drug Administration (Drugs@FDA, openFDA)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Group
- Amneal
- Headquarters
- United States
- Medicines
- 2
- Countries
- 1
- Roles
- Authorisation holder